These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 27221755)

  • 1. The membrane tethered matrix metalloproteinase MT1-MMP at the forefront of melanoma cell invasion and metastasis.
    Thakur V; Bedogni B
    Pharmacol Res; 2016 Sep; 111():17-22. PubMed ID: 27221755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MT1-MMP modulates melanoma cell dissemination and metastasis through activation of MMP2 and RAC1.
    Shaverdashvili K; Wong P; Ma J; Zhang K; Osman I; Bedogni B
    Pigment Cell Melanoma Res; 2014 Mar; 27(2):287-96. PubMed ID: 24387669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor cell invasion of collagen matrices requires coordinate lipid agonist-induced G-protein and membrane-type matrix metalloproteinase-1-dependent signaling.
    Fisher KE; Pop A; Koh W; Anthis NJ; Saunders WB; Davis GE
    Mol Cancer; 2006 Dec; 5():69. PubMed ID: 17156449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tetraspanin CD81 protein increases melanoma cell motility by up-regulating metalloproteinase MT1-MMP expression through the pro-oncogenic Akt-dependent Sp1 activation signaling pathways.
    Hong IK; Byun HJ; Lee J; Jin YJ; Wang SJ; Jeoung DI; Kim YM; Lee H
    J Biol Chem; 2014 May; 289(22):15691-704. PubMed ID: 24733393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
    Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
    J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MT1-MMP dependent repression of the tumor suppressor SPRY4 contributes to MT1-MMP driven melanoma cell motility.
    Shaverdashvili K; Zhang K; Osman I; Honda K; Jobava R; Bedogni B
    Oncotarget; 2015 Oct; 6(32):33512-22. PubMed ID: 26392417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The thiirane-based selective MT1-MMP/MMP2 inhibitor ND-322 reduces melanoma tumor growth and delays metastatic dissemination.
    Marusak C; Bayles I; Ma J; Gooyit M; Gao M; Chang M; Bedogni B
    Pharmacol Res; 2016 Nov; 113(Pt A):515-520. PubMed ID: 27687955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix invasion by tumour cells: a focus on MT1-MMP trafficking to invadopodia.
    Poincloux R; Lizárraga F; Chavrier P
    J Cell Sci; 2009 Sep; 122(Pt 17):3015-24. PubMed ID: 19692588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane type-1 matrix metalloproteinase promotes human melanoma invasion and growth.
    Iida J; Wilhelmson KL; Price MA; Wilson CM; Pei D; Furcht LT; McCarthy JB
    J Invest Dermatol; 2004 Jan; 122(1):167-76. PubMed ID: 14962105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CDCP1 regulates the function of MT1-MMP and invadopodia-mediated invasion of cancer cells.
    Miyazawa Y; Uekita T; Ito Y; Seiki M; Yamaguchi H; Sakai R
    Mol Cancer Res; 2013 Jun; 11(6):628-37. PubMed ID: 23439492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective function-blocking monoclonal human antibody highlights the important role of membrane type-1 matrix metalloproteinase (MT1-MMP) in metastasis.
    Remacle AG; Cieplak P; Nam DH; Shiryaev SA; Ge X; Strongin AY
    Oncotarget; 2017 Jan; 8(2):2781-2799. PubMed ID: 27835863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gallic acid inhibits the migration and invasion of A375.S2 human melanoma cells through the inhibition of matrix metalloproteinase-2 and Ras.
    Lo C; Lai TY; Yang JS; Yang JH; Ma YS; Weng SW; Lin HY; Chen HY; Lin JG; Chung JG
    Melanoma Res; 2011 Aug; 21(4):267-73. PubMed ID: 21734530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteopontin stimulates tumor growth and activation of promatrix metalloproteinase-2 through nuclear factor-kappa B-mediated induction of membrane type 1 matrix metalloproteinase in murine melanoma cells.
    Philip S; Bulbule A; Kundu GC
    J Biol Chem; 2001 Nov; 276(48):44926-35. PubMed ID: 11564733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic effect of blocking cancer cell invasion revealed by computer simulations.
    Ichikawa K
    Math Biosci Eng; 2015 Dec; 12(6):1189-202. PubMed ID: 26775856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MT1-MMP and integrins: Hand-to-hand in cell communication.
    Gonzalo P; Moreno V; Gálvez BG; Arroyo AG
    Biofactors; 2010; 36(4):248-54. PubMed ID: 20818710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of matrix metalloproteinase-2 and -9 and membrane-type 1 matrix metalloproteinase in melanocytic tumors of dogs and canine melanoma cell lines.
    Docampo MJ; Cabrera J; Rabanal RM; Bassols A
    Am J Vet Res; 2011 Aug; 72(8):1087-96. PubMed ID: 21801067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Next generation matrix metalloproteinase inhibitors - Novel strategies bring new prospects.
    Levin M; Udi Y; Solomonov I; Sagi I
    Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt A):1927-1939. PubMed ID: 28636874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Less is more: low expression of MT1-MMP is optimal to promote migration and tumourigenesis of breast cancer cells.
    Cepeda MA; Pelling JJ; Evered CL; Williams KC; Freedman Z; Stan I; Willson JA; Leong HS; Damjanovski S
    Mol Cancer; 2016 Oct; 15(1):65. PubMed ID: 27756325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinase expression in malignant melanomas: tumor-extracellular matrix interactions in invasion and metastasis.
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    In Vivo; 2001; 15(1):57-64. PubMed ID: 11286131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of membrane type 1 matrix metalloproteinase by LPS and gamma interferon bound to extracellular matrix in intestinal crypt cells.
    Alvarado J; del Castillo JR; Thomas LE
    Cytokine; 2008 Feb; 41(2):155-61. PubMed ID: 18165051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.